Skip to Content on Nemours.org

Clinical Trial

Offered by: Nemours Children's
Locations: Delaware Valley, Jacksonville, Fla., Orlando and Pensacola, Fla.

Trial Name

A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients With Recurrent, Refractory, or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas

What is the trial about?

To find out what effects low and high doses of lenalidomide have on children, adolescents, and young adults with recurrent/refractory/progressive JPA or OPG.

Who can participate?

Children with juvenile pilocytic astrocytomas (JPA) or an optic pathway glioma (OPG).

What is involved?

Length of study is 24 months. Standard cancer care.

Contact Nemours Children's Clinical Trials

Trial Name: A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients With Recurrent, Refractory, or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas

ACNS#: 1022

(800) 354-5690 Email Us

Is a Clinical Trial Right for Your Child?

Learn more about clinical trials and get answers to questions you might have.

Go to FAQs View All Clinical Trials
Two researchers in a lab wearing coats and gloves, one looks into a microscope.